Amezinium metilsulfate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Amezinium metilsulfate
Amezinium metilsulfate.png
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.045.665
Chemical and physical data
Formula C12H15N3O5S
Molar mass 313.32 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.[1][2]

References[edit]

  1. ^ Araújo, D; Caramona, MM; Osswald, W (1983). "On the mechanism of action of amezinium methylsulphate on the dog saphenous vein". European Journal of Pharmacology. 90 (2–3): 203–14. PMID 6873182. doi:10.1016/0014-2999(83)90238-8. 
  2. ^ Lenke, D.; Gries, J.; Kretzschmar, R. (1981). "Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action". Arzneimittel-Forschung. 31 (9a): 1558–1565. PMID 7197970.